|
Assessment Of Microbiological Sterility In Radioimmunoassay Laboratory Using SCDM And FTM Materials
[Full Text]
AUTHOR(S)
Yousif Mohamed Y. Abdallah, Mohamed E.M. Gar-elnebi, Waleed A. Almahi, Nahid M. Matar, Nagi I. Ali
KEYWORDS
Index Terms: Nuclear medicine, Radioimmunoassay Laboratory, sterility.
ABSTRACT
Abstract: This was an experimental study deal with assessment of radiobiological sterility in Radioimmunoassay (RIA) lab. The importance of this study is to highlight the importance of the quality assurance program in nuclear medicine department.. For RIA, the laboratory was tested sterility and apyrogenicity testing determination. The sample of culture media –SCDM and FTM Anaerobic bacteria validation of sterility test with known strains of bacteria, virus and fungi. The SCDM and FTM were put for 24 hours and after that analyzed in microbiological laboratory. The results of sample were 1 colonel yeast cell, 11 colonels of gram negative Bacilli and 3 colonels of Staphococcus detected.
REFERENCES
[1] Adam MJ, Wilbur DS (2005) Radiohalogens for imaging and therapy. Chem Soc Rev 34:153–63
[2] Alauddin MM, Conti PS (1998) Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl) guanine ([18F] FHBG): a new potential imaging agent for viral infection and gene therapy using PET.Nucl Med Biol 25: 175–180
[3] Alberto R, Schibli R, Egli A, Schubiger AP, Abram U, Kaden TA (1998) A novel organometallic aqua complex of technetium for the labeling of biomolecules: synthesis of [99mTc(OH2)3(CO)3]+ from [99mTcO4]– in aqueous solution and its reaction with a bifunctional ligand. J Am Chem Soc 120(31):7987–798
[4] Alrabiah FA, Sacks SL (1996) New anti-herpes virus agents: their targets and therapeutic potential. Drugs 52:17–32
[5] Anderson C (1933) The positive electron. Phys Rev 43(6): 491–494
[6] Anderson CJ, Dehdashti F, Cutler PD, et al. (2001) Copper-64- TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors. J Nucl Med 42:213–221
[7] Antoni G, Langstrom B (2005) Progress in 11C radiochemistry. In: Bailey DL, Townsend DW, Valk PE,MaiseyMN(eds) Positron emission tomography – basic sciences. Springer-Verlag, London, pp 223–236
[8] Baeken C, D’haenen H, Flamen P, Mertens J, Terriere D, Chavatte K, Boumon R, Bossuyt A (1998) 123I-5-I-R91150, anew single-photon emission tomography ligand for 5-HT2 A receptors: influence of age and gender in healthy subjects. Eur J Nucl Med 25(12):1617–22
[9] Banati RB, Goerres GW, Myers R, et al. (1999) [11C](R)- PK11195 positron emission tomography imaging of activatedmicroglia in vivo in Rasmussen’s encephalitis.Neurology 53:2199–2203
[10] Bangard M, Behe M, Guhlke S, Otte R, Bender H, Maecke HR, Biersack HJ (2000) Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1- Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide. Eur J NuclMed 27(6): 628–37
[11] Barrio JR, Huang S-C, Cole G, et al. (1997) PET imaging of tangles and plaques in Alzheimer’s disease with a highly hydrophobic probe. J Label Compd Radiopharm 42:S194–S195
[12] Bass LA,Wang M,Welch MJ, Anderson CJ (2000) In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bioconjugate Chem 11:527–532
[13] Bergmann SR, Fox KA, Rand AL, et al. (1984) Quantification of regional myocardial blood flow in vivo with [15O]water. Circulation 70:724–733
[14] Bjurling P,Watanabe Y, Tokushige M, et al. (1989) Synthesis of q -11C-labeled L-tryptophan and 5-hydroxy-L-tryptophan using a multi-enzymatic reaction route. J Chem Soc Perkin Trans 1:1331–1334
[15] BlockD, CoenenHH, Stocklin G, et al. (1987) TheNCA nucleophilic 18F-fluorination of I,N-disubstituted alkanes as fluoralkylation agents. J Label Compd Radiopharm 24:1029–42
[16] Blower PJ, Kettle AG, O’Doherty MJ, Coakley AJ, Knapp FF, Jr (2000) 99mTc(V)DMSA quantitatively predicts 188Re(V)- DMSA distribution in patients with prostate cancer metastatic to bone. Eur J Nucl Med 27(9):1405–9 72 2 Radiochemistry and Radiopharmacy
[17] Blower PJ, Lewis JS, Zweit J (1996) Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl Med Biol 23(8):957–980
[18] Boswell CA, Sun X, NiuW, et al. (2004) Comparative in vivo stability of copper-64 labeled cross-bridged and conventional tetraazamacrocyclic complexes. J Med Chem 47:1465–1474
|
